About
About
Shield Therapeutics is a well-funded, high potential, commercial stage specialty-pharma company. We pride ourselves on providing solutions to unmet medical needs and delivering value to our shareholders.
Explore section
Our Strategy and Values

People
Lead Products
Lead Products
Shield has a rare opportunity to build an integrated, highly profitable specialty pharma business. In this section you can learn more about our lead product, and about our second asset.
Explore section
Feraccru^® / Accrufer^®
Pipeline product candidates
Partnering
Investors
Investors
Shield is well positioned to become a fast growing, independent, international specialty pharmaceutical company due to the strength of its products and team, and with great thanks to all of our supportive shareholders.
RNS News

Share Price Summary

Corporate Governance

AIM Rule 26

Video and Audio

Investor Contacts

Corporate Documents

Presentations

Advisor Contacts

Financial Calendar

Analyst Coverage
News
Events

Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Corporate Documents

2016 Interim Report

Type:

PDF

Date:

20 Sep 2016

2016 Interims Press Release

Type:

PDF

Date:

20 Sep 2016

Notice of Annual General Meeting 2016

Type:

PDF

Date:

15 Jul 2016

Annual Report 2015

Type:

PDF

Date:

30 Jun 2016

Maiden Prelims Press Release

Type:

PDF

Date:

14 Jun 2016

Admission Document

Type:

PDF

Date:

12 Jun 2016

Shield Therapeutics Announces Successful Placing to Raise £32.5 Million and Proposed Admission to AIM

Type:

PDF

Date:

12 Jun 2016

Warrant Instrument

Type:

PDF

Date:

12 Jun 2016

Articles of Association

Type:

PDF

Date:

12 Jun 2016

Memorandum of Association

Type:

PDF

Date:

12 Jun 2016

Investors

Corporate Documents

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Type:

Date:

Sign up for news